LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

Home・Akciju saraksts・Microbot Medical Inc

Microbot Medical Inc

Slēgts

3.3 -1.49

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3.16

Max

3.4

Galvenie mērījumi
By Trading Economics
Ienākumi	-899K -3.5M
Peļņas marža	-4,038.095
Darbinieki	20
EBITDA	-84K -3.5M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+259.28% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2025. g. 11. nov.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	38M 166M
Iepriekšējā atvēršanas cena	4.79
Iepriekšējā slēgšanas cena	3.3

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

2.52 / 2.57 Atbalsts un pretestība

Microbot Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 16. sept. 17:03 UTC

Galvenie tirgus virzītāji

BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment

2025. g. 16. sept. 16:49 UTC

Galvenie tirgus virzītāji

Iegādes, apvienošanās, pārņemšana

GD Culture Shares Drop After Deal for Pallas Capital

2025. g. 16. sept. 16:11 UTC

Galvenie tirgus virzītāji

Corbus Shares Rise on FDA Fast-Track Designation for Cancer Drug

2025. g. 16. sept. 23:40 UTC

Tirgus saruna

Nikkei May Decline as Yen Strengthens -- Market Talk

2025. g. 16. sept. 23:34 UTC

Tirgus saruna

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

2025. g. 16. sept. 23:20 UTC

Tirgus saruna

Restaurant Brands NZ Can Outperform When Cycle Turns -- Market Talk

2025. g. 16. sept. 21:10 UTC

Iegādes, apvienošanās, pārņemšana

U.S. Investors, Trump Close In on TikTok Deal With China -- WSJ

2025. g. 16. sept. 20:51 UTC

Tirgus saruna

U.S. Home Sales, New Home Listings Fall in August -- Market Talk

2025. g. 16. sept. 20:50 UTC

Tirgus saruna

Energy & Utilities Roundup: Market Talk

2025. g. 16. sept. 20:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2025. g. 16. sept. 20:25 UTC

Peļņas

The AI Trade Has Stocks Near Highs Again. Some Tech Names Remain on the Sidelines -- Barrons.com

2025. g. 16. sept. 20:24 UTC

Peļņas

These Stocks Moved the Most Today: Oracle, Tesla, Alphabet, Dave & Buster's, Chipotle, and More -- Barrons.com

2025. g. 16. sept. 19:19 UTC

Tirgus saruna

U.S. Natural Gas Futures Extend Winning Streak -- Market Talk

2025. g. 16. sept. 18:52 UTC

Tirgus saruna

Oil Futures Advance on Russia Concerns, Weak Dollar -- Market Talk

2025. g. 16. sept. 18:44 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. sept. 18:44 UTC

Tirgus saruna

EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk

2025. g. 16. sept. 18:40 UTC

Iegādes, apvienošanās, pārņemšana

Details Emerge on U.S.-China TikTok Deal -- WSJ

2025. g. 16. sept. 18:38 UTC

Tirgus saruna

Meta Seen With Long-Term Opportunity to Lead in Smart Glasses -- Market Talk

2025. g. 16. sept. 18:19 UTC

Tirgus saruna

Gold Settles at New High Ahead of Fed Decision -- Market Talk

2025. g. 16. sept. 18:01 UTC

Tirgus saruna

U.S. Dollar Weakness Supports Oil's Gains -- Market Talk

2025. g. 16. sept. 17:34 UTC

Tirgus saruna

Any Question the Bank of Canada Will Cut Now Look to Have Vanished -- Market Talk

2025. g. 16. sept. 16:53 UTC

Peļņas

Software Companies Are Fighting Back With AI. The Stocks Are Still Hurting. -- Barrons.com

2025. g. 16. sept. 16:20 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2025. g. 16. sept. 16:15 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Commodities Roundup: Market Talk

2025. g. 16. sept. 16:09 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Energy Roundup: Market Talk

2025. g. 16. sept. 16:09 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Canada Industry Minister to Meet Mining CEOs on Merger -- Market Talk

2025. g. 16. sept. 15:35 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. sept. 15:35 UTC

Tirgus saruna

Gold Soars Past $3,700 Ahead of Fed Decision -- Market Talk

2025. g. 16. sept. 15:22 UTC

Tirgus saruna

More Investors Think Dollar is Overvalued in Latest BofA Survey -- Market Talk

2025. g. 16. sept. 15:21 UTC

Tirgus saruna

Sterling Considered Most Overvalued in Nearly 10 Years -- Market Talk

Salīdzinājums

Cenas izmaiņa

Microbot Medical Inc Prognoze

Cenas mērķis

By TipRanks

259.28% augšup

Prognoze 12 mēnešiem

Vidējais 12 USD 259.28%

Augstākais 12 USD

Zemākais 12 USD

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

1 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 1 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.52 / 2.57Atbalsts un pretestība

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.